Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX10 + chemotherapy
Cervical Cancer
phase 2


A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy

HLX10+Chemotherapy
Extensive Stage Small Cell Lung Cancer
Phase 3
A Randomized, Double-blind, Placebo?Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
HLX10+chemotherapy
Squamous Non Small Cell Lung Cancer
Phase 3
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
HLX10+Chemotherapy
Esophageal Squamous Cell Carcinoma
Phase 3
A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
HLX10+Chemotherapy
Non-Small-Cell Lung Cancer
Phase 3
A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
制作小米手机主题赚钱 现在炒股的人多吗 香港6合宝典彩图2020 金牛配资官方网站 河北十一选五怎么跟号 山东快乐扑克3今天 平特两肖怎么买 asg游戏理财平台 时时彩平台注册 贵州体彩11选5走势图 捕鱼大师1.1.9